ThruFlo Endovascular
PrivateLast Round
Seed
Jun 10, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ThruFlo Endovascular, Inc. is a medical device company that develops and markets advanced endovascular devices for the treatment of Branch Point Aneurysms.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ThruFlo Endovascular Comparables
Compare ThruFlo Endovascular with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NV MedTech | 87% | |
| Oxford Endovascular | 82% | |
| Acandis | 78% | |
ThruFlo Endovascular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 10, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 10, 2026
Completed a Seed funding round.
ThruFlo Endovascular Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ThruFlo Endovascular's valuation, stock price, and market status.